RSV causes a respiratory tract infection that affects 64 million people per year worldwide. It hospitalizes 3 million children under 5 years old and approximately 336,000 older adults annually (Lancet 2020). After decades of research, hope is on the horizon for a vaccine to prevent this devastating disease. Join Dr. Carlson for a conversation about RSV, this deadly virus. What causes RSV? What are the treatment options? How far out are we from a vaccine to make RSV a preventable disease?
I imagine there is a different answer with every person who is asked. And I’m sure each answer would be as true as the last. Incredible inventions have changed our lives and continue to do so. As a medical provider I have witnessed some awesome medical inventions that have saved and improved lives.
Ever wonder how your medicine makes it to the pharmacy? The Covid-19 pandemic has given us a glimpse into the world of drug development. It’s a fascinating process and has been perfected over time to ensure that the medicine we take every day to ease our pain and keep us functioning is safe. This blog shares with you the 5 steps in the drug development process in the US.
I apologize for the glib title. There is no doubt, this pandemic has been devastating. However, trying to find the good in something bad is my intent. Allow me to list some of the silver linings to this dark cloud that we hope to see clearing soon.
Meningococcal disease is a devastating infection, a key cause of meningitis, sepsis, and, less often, pneumonia, pericarditis, and septic arthritis. Neisseria meningitidis (the bacteria that causes the disease) tends to strike young, otherwise well individuals and can progress to death in a matter of hours.